Advertisement

Topics

Latest Assays NewsRSS

09:21 EST 19th November 2017 | BioPortfolio

Ncardia Announces Completion of €10.5M Investment Round

Stem cell technology innovator continues rapid growth, plans further global expansion to become the global leader in hiPSC-based drug discovery & development solutions Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced plu...

Global Oxidative Stress Assay Market Research Report Forecast 2017 to 2021 [Report Updated: 30102017] Prices from USD $2800

The Global Oxidative Stress Assay Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Oxidative Stress Assay industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description of the value chain and its distributor analy...

Invisible Sentinel Further Empowers Brewing Quality with Launch of Innovative real-time PCR assay, brewPRO™

brewPRO™ is the first assay for Invisible Sentinel’s new molecular detection platform, Veripro™, featuring superior ease of use, multiplexing and high throughput analyses PHILADELPHIA (PRWEB) November 16, 2017 Invisible Sentinel Inc., a Philadelphia-based global molecular solutions company announces commercialization of its real-time PCR platform, Veripro™, and the first assay available o...

LabCorp Announces New Expanded Use for PD-L1 Test with Bristol-Myers Squibb’s OPDIVO®

LabCorp Performed Testing for Studies Supporting Approval of Two New Complementary Diagnostic Indications in Connection with the Treatment of Bladder Cancer and Cancer of the Head and Neck LabCorp (NYSE: LH) a leading global life sciences company, today announced the U.S. availability of the PD-L1 IHC 28-8 pharmDx assay as a complementary diagnostic fo...

#jobs #lifescience Covance UK: Assay Development Scientist – Harrogate, UK

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Covance UK: Assay Development Scientist – Harrogate, UK . competitive: Covance UK: We are currently recruiting for an Assay Development Scientist for our Biosimilars team. Harrogate, North Yorkshire … Continue reading → Cet article #jobs #lifescience Covance ...

Global LFA Lateral Flow Assay Market Research Report Forecast 2017 to 2022 [Report Updated: 23102017] Prices from USD $2800

Delivery of the Report will take 23 working days once order is placed.The Global LFA Lateral Flow Assay Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the LFA Lateral Flow Assay industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provi...

Idengene SA to Bring Contextual Genomics’ Revolutionary Cancer Genomic Test Find-It™ to Brazil

Find-It™ screens for more than 140 somatic genome alterations in cancer patients Idengene SA will offer Find-It™ in Brazil in Q1 2018 through an exclusive distributorship with Contextual Genomics Partnership includes access to future cancer assays from the Contextual Genomics pipeline Brazi...

PerkinElmer Launches chemagic™ Prime™ Instrument for Automated Nucleic Acid Isolation and Assay Set-Up

Leverages Advanced Magnetic Bead-Based Technology to Support Next Gen Sequencing, Genotyping, PCR and MLPA in Human Samples   PerkinElmer, Inc., has announced the launch of its chemagic™ Prime™ instrument, a new streamlined, walk-away sample processing solution which offers automated nucleic acid isolation and assay setup by combining PerkinElmer’s chemagic™...

EKF Procalcitonin Assay FDA Cleared and Validated for Beckman AU Chemistry Analyzers

User defined application available on Beckman AU clinical chemistry analyzers for LiquiColor® Procalcitonin (PCT) assay enabling quick and effective sepsis identification

Invivoscribe Releases LymphoTrack TRB Assay on MiSeq and LymphoTrack...

InvivoscribeA Technologies Inc., a global company with decades of experience providing clonality and biomarker test solutions for the fields of oncology and personalized molecular medicineA , announces the release of the Research Use Only version of its LymphoTrackA TRB Assay for the Illumina MiSeqA platform. Included with the assay is specialized bioinformatics software that allows researchers an...

SYGNIS AG partners with Abingdon Health to provide full service custom lateral flow assay design and supply

Cambridge, UK, 07 November 2017: SYGNIS AG, under the Innova Biosciences (Innova) brand name, a specialist provider of bioconjugation products and services, today announced it has established a partnership with Abingdon Health Ltd (“Abingdon”), which will enable Innova to provide its customers with full lateral flow assay development services as well as establishing Innova as the ...

Invivoscribe® Releases LymphoTrack® TRB Assay on MiSeq® and LymphoTrack® Minimal Residual Disease (MRD) Software

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Invivoscribe® Technologies Inc., a global company with decades of experience providing clonality and biomarker test solutions for the fields of oncology and personalized molecular medicine®, announces the release of the Research Use Only (RUO) version of its LymphoTrack® TRB Assay for the Illumina MiSeq® platform. Included with the assay i...

Adaptive Biotechnologies Announces a Collaboration with Amgen to Advance Clinical Development of the clonoSEQ® Assay in Multiple Myeloma

Adaptive Biotechnologies, a leader in combining next-generation sequencing (NGS) and sophisticated bioinformatics to profile T- and B-cell receptors of the adaptive immune system, announces it has entered into a collaboration agreement with Amgen to utilize Adaptive’s NGS-based clonoSEQ Assay in the Phase 3 CANDOR study, sponsored by Amgen in collaborati...

Advice for alternative medicine practitioners: Stay in your lane

Dear alternative medicine, Hi, it’s HD again. You may remember me from the last time we entered the squared circle, “Endocrinology vs. Naturopathy: Steel Cage Death Match.” I had hoped that you might internalize a couple of the lessons I tried to teach you: “Know your assay” and “know your pre-test probability” — but, shocker, […]

Quanterix Corp Medical Equipment Deals and Alliances Profile [Report Updated: 26102017] Prices from USD $250

SummaryQuanterix Corp Quanterix is a medical equipment provider that offers proteins measurement solutions. The company's products comprise simoa HD1 analyzer, assay kits and consumables. It provides assay kits such as Cpeptide simoa assay kit, homebrew assay kit, homebrew bead and SBG kit, PSA simoa assay kit, tau simoa assay kit and TNFa simoa assay kit. Quanterix's products are used in life sci...

Cell-line Derived Controls for Diagnostic Assay Development

AMSBIO announce the addition of mutation cell line Formalin-Fixed Paraffin-Embedded (FFPE) samples and isolated genomic DNA (gDNA) controls to its extensive range of cell line reference standards. In both routine clinical use and diagnostic assay development, biologically-relevant positive and negative controls represent an invaluable resource. To ensure accuracy and reproducibility during IVD ass...

Global Polyethylene Imine Market Analysis 20112017 and Forecast 20182023 [Report Updated: 08092017] Prices from USD $2980

SnapshotPolyethylenimine PEI is a polymer with repeating unit composed of the amine group and two carbon aliphatic CH2CH2 spacer. Linear polyethyleneimines contain all secondary amines, in contrast to branched PEIs which contain primary, secondary and tertiary amino groups. Totally branched, dendrimeric forms were also reported. PEI is produced on industrial scale and finds many applications usual...

Latent Tuberculosis Screening in Non-U.S.-Born Residents

The interferon gamma release assay is a preferred strategy for latent tuberculosis infection screening in HIV-negative, non-U.S.-born residents.

Advanced Cell Diagnostics Showcases the Characterization of Immune Checkpoint Expression

LabRoots will host the webinar November 15, in which participants will learn about the expression and co-expression profiles of therapeutic checkpoint targets. YORBA LINDA, Calif. (PRWEB) October 30, 2017 Interactions between tumor and immune cells in the tumor microenvironment (TME) play a key role in tumor progression and treatment response, with accumulating evidence indicating a crucial role ...

Global and Asia 2Methyl1, 3Propanediol Market Status and Future Forecast 20132023 [Report Updated: 18102017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

New Study Published in JAMA Oncology Shows MammaPrint® Changed Breast Cancer Treatment Decisions in 3 out of 4 Cases where Guidance was Unclear with the 21-Gene Assay.

Prospective PROMIS trial showed no correlation between the two tests highlighting potential under-and over-treatment risks throughout the 21-gene assay’s intermediate range Physicians changed their treatment decisions in approximately 34% of all cases and in 76% of cases where treatment decisions were discordant based on the indication of the MammaPrint test, with 79% of physicians ...

SYGNIS AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing

Unique kit enables the fast and easy development of customized sandwich lateral flow assays

Mercodia Releases Unique Multiplex Assay in Collaboration with Quansys

Uppsala, Sweden, October 27, 2017 --(PR.com)-- For many years, multiplex assays have been plagued by a lack of specificity and accuracy, with unreliable data as a result. Unreliable data can lead a scientific project in the wrong direction - a detour that could prove to be both costly and time consuming. However, a new multiplex assay has reached the US market. Mercodia, based in Sweden, has team...

New Study Published in JAMA Oncology Shows MammaPrint® Changed Breast Cancer Treatment Decisions in 3 out of 4 Cases where Guidance was Unclear with the 21-Gene Assay

Prospective PROMIS trial showed no correlation between the two tests highlighting potential under-and over-treatment risks throughout the 21-gene assay’s intermediate range Physicians changed their treatment decisions in approximately 34% of all cases and in 76% of cases where treatment decisions were discordant based on t...

AMSBIO Launch Mutation Cell-Line Derived Controls

AMSBIO announce the addition of mutation cell line Formalin-Fixed Paraffin-Embedded (FFPE) samples and isolated genomic DNA (gDNA) controls to its extensive range of cell line reference standards. In both routine clinical use and diagnostic assay development, biologically-relevant positive and negative controls represent an invaluable resource. To ensure accuracy and reproducibility during IVD ass...

Quick Search
Advertisement
 

review and buy Assays market research data and corporate reports here